UroGen Pharma Ltd. Other Current Liabilities
UroGen Pharma Ltd. (URGN) had Other Current Liabilities of $7.62 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Current $7.62M.
- 2026-03-31: Other Liabilities, Current $5.45M.
- 2025-12-31: Other Liabilities, Current $3.43M; Other Liabilities, Current as first filed $5.18M.
- 2025-09-30: Other Liabilities, Current $4.96M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.62M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $5.45M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $3.43M 10-Q · filed 2026-08-05 | $5.18M 10-K · filed 2026-03-02 |
| 2025-09-30 | $4.96M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.94M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.71M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $7.95M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $4.07M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $3.62M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.20M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $3.86M 10-K · filed 2025-03-10 | |
| 2023-09-30 | $3.55M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.64M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.19M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.28M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $3.02M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.96M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.01M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.33M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $2.27M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.94M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.74M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.86M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $1.33M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.48M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.63M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.58M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.07M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.00M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |